Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Serum Granulysin as a Possible Key Marker to Detect the Severity of Psoriasis

NCT03469219 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.

NCT NCT03469219
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03469219 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Serum Granulysin as a Possible Key Marker to Detect the Severity of Psoriasis
Lead sponsor
Assiut University
Phase
Observational
Overall status
Unknown status
Start date
July 31, 2018
Completion date
March 31, 2019
Enrollment
45 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis vulgaris